drugset / Trial / NCT02665910
Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Condition: Rheumatoid Arthritis Intervention: Drug: SHR0302; Drug: SHR0302 placebo comparator Phase: Phase 1 Study Type: Interventional Study Design: Treatment, Parallel Assignment, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Randomized
Timeline
- Start
- 2016-05
- Primary completion
- 2016-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR0302 | Unknown | 1 mg | Oral |
| Subject | SHR0302 | Unknown | 2 mg | Oral |
| Subject | SHR0302 | Unknown | 5 mg | Oral |
| Subject | SHR0302 | Unknown | 10 mg | Oral |
| Subject | SHR0302 | Unknown | 25 mg | Oral |